Log in

NASDAQ:CAPRCapricor Therapeutics News Headlines

$4.38
-0.18 (-3.95 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.32
Now: $4.38
$4.56
50-Day Range
$4.28
MA: $4.76
$5.39
52-Week Range
$0.88
Now: $4.38
$11.08
Volume489,500 shs
Average Volume808,316 shs
Market Capitalization$62.46 million
P/E RatioN/A
Dividend YieldN/A
Beta6.83

Headlines

Capricor Therapeutics (NASDAQ CAPR) News Headlines

Source:
DateHeadline
CAPR Capricor Therapeutics, Inc. Common StockCAPR Capricor Therapeutics, Inc. Common Stock
www.nasdaq.com - July 4 at 7:19 PM
Clinical Trials Market Analysis, Trends and CAGR Projections 2020-2027Clinical Trials Market Analysis, Trends and CAGR Projections 2020-2027
www.marketwatch.com - June 17 at 11:28 PM
Epithelial Stem Cells Market Set For Rapid Growth and Trend | Statistics Analysis and Opportunities 2025 |3Dmatrix, Aldagen, Athersys, Gamida CellEpithelial Stem Cells Market Set For Rapid Growth and Trend | Statistics Analysis and Opportunities 2025 |3Dmatrix, Aldagen, Athersys, Gamida Cell
www.marketwatch.com - June 16 at 2:40 PM
Capricor Therapeutics Inc.Capricor Therapeutics Inc.
www.barrons.com - June 10 at 3:13 PM
Thinking about buying stock in Lakeland Industries, Capricor Therapeutics, T2 Biosystems, Callon Petroleum, or TOP Ships?Thinking about buying stock in Lakeland Industries, Capricor Therapeutics, T2 Biosystems, Callon Petroleum, or TOP Ships?
www.benzinga.com - June 10 at 10:13 AM
Here is What Hedge Funds Think About Capricor Therapeutics, Inc. (CAPR)Here is What Hedge Funds Think About Capricor Therapeutics, Inc. (CAPR)
finance.yahoo.com - May 29 at 2:24 PM
Capricor to Participate in Maxim Groups COVID-19 Virtual Conference Series on May 27, 2020Capricor to Participate in Maxim Group's COVID-19 Virtual Conference Series on May 27, 2020
finance.yahoo.com - May 26 at 12:54 PM
Capricor Therapeutics Inc. (CAPR) CEO Linda Marban on Q1 2020 Results - Earnings Call TranscriptCapricor Therapeutics Inc. (CAPR) CEO Linda Marban on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 18 at 1:10 PM
Capricor Therapeutics, Inc. 2020 Q1 - Results - Earnings Call PresentationCapricor Therapeutics, Inc. 2020 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 18 at 8:09 AM
BRIEF-Capricor Therapeutics Reports Q1 Loss Per Share Of $0.30BRIEF-Capricor Therapeutics Reports Q1 Loss Per Share Of $0.30
www.reuters.com - May 14 at 11:18 PM
Capricor Therapeutics EPS beats by $0.07, misses on revenueCapricor Therapeutics EPS beats by $0.07, misses on revenue
seekingalpha.com - May 14 at 6:17 PM
Capricor Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate UpdateCapricor Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - May 14 at 6:17 PM
Capricor Therapeutics to Present First Quarter 2020 Financial Results and Recent Corporate Update on May 14Capricor Therapeutics to Present First Quarter 2020 Financial Results and Recent Corporate Update on May 14
finance.yahoo.com - May 13 at 8:53 PM
Thinking about buying stock in Capricor Therapeutics, Waitr, Takeda Pharmaceutical, Sorrento Therapeutics, or Inovio Pharmaceuticals?Thinking about buying stock in Capricor Therapeutics, Waitr, Takeda Pharmaceutical, Sorrento Therapeutics, or Inovio Pharmaceuticals?
www.prnewswire.com - May 13 at 9:58 AM
Capricor reports positive data from mid-stage study of CAP-1002 in DMDCapricor reports positive data from mid-stage study of CAP-1002 in DMD
seekingalpha.com - May 13 at 9:58 AM
Capricor Announces Positive Top-Line Final Results from HOPE-2 Study in Patients with Duchenne Muscular Dystrophy Treated with Lead Candidate CAP-1002Capricor Announces Positive Top-Line Final Results from HOPE-2 Study in Patients with Duchenne Muscular Dystrophy Treated with Lead Candidate CAP-1002
finance.yahoo.com - May 13 at 9:58 AM
Capricor (CAPR) Shares Could Hit $10, Says AnalystCapricor (CAPR) Shares Could Hit $10, Says Analyst
finance.yahoo.com - May 7 at 4:22 PM
BRIEF-Capricor Therapeutics Inc Files For Offering Of Up To $40.0 MillionBRIEF-Capricor Therapeutics Inc Files For Offering Of Up To $40.0 Million
www.reuters.com - May 4 at 9:42 PM
61 Stocks Moving In Thursdays Mid-Day Session61 Stocks Moving In Thursday's Mid-Day Session
www.msn.com - May 1 at 2:49 AM
PSTI, IMMU And CAPR Are Trading Above Their 50-Days Moving Average And Heres WhyPSTI, IMMU And CAPR Are Trading Above Their 50-Days Moving Average And Here's Why
www.marketwatch.com - April 30 at 4:48 PM
Capricor Therapeutics Shares Soar 250% On Successful COVID-19 Treatment NewsCapricor Therapeutics Shares Soar 250% On Successful COVID-19 Treatment News
www.benzinga.com - April 30 at 1:09 AM
Stock Alert: Capricor Therapeutics Jumps 80% On Positive COVID-19 Treatment DataStock Alert: Capricor Therapeutics Jumps 80% On Positive COVID-19 Treatment Data
www.nasdaq.com - April 30 at 1:09 AM
BRIEF-New Capricor Data Reports 100% Survival In Critical Covid-19 Patients Treated With Cap-1002BRIEF-New Capricor Data Reports 100% Survival In Critical Covid-19 Patients Treated With Cap-1002
www.reuters.com - April 29 at 8:09 PM
BUZZ-U.S. STOCKS ON THE MOVE-Liberty Oilfield, MRC Global, Capricor TherapeuticsBUZZ-U.S. STOCKS ON THE MOVE-Liberty Oilfield, MRC Global, Capricor Therapeutics
www.nasdaq.com - April 29 at 3:08 PM
RRD, SM, NAT and HTZ among midday moversRRD, SM, NAT and HTZ among midday movers
seekingalpha.com - April 29 at 3:08 PM
Capricor rockets 181% on CAP-1002s effect in COVID-19 patientsCapricor rockets 181% on CAP-1002's effect in COVID-19 patients
seekingalpha.com - April 29 at 3:08 PM
BUZZ-U.S. STOCKS ON THE MOVE-Capricor Therapeutics, Liberty Oilfield, Blue ApronBUZZ-U.S. STOCKS ON THE MOVE-Capricor Therapeutics, Liberty Oilfield, Blue Apron
www.nasdaq.com - April 29 at 3:08 PM
New Capricor Data Reports 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002New Capricor Data Reports 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002
finance.yahoo.com - April 29 at 3:08 PM
Did You Manage To Avoid Capricor Therapeutics (NASDAQ:CAPR) 97% Share Price Wipe Out?Did You Manage To Avoid Capricor Therapeutics' (NASDAQ:CAPR) 97% Share Price Wipe Out?
finance.yahoo.com - April 24 at 9:33 AM
Did You Manage To Avoid Capricor Therapeutics' (NASDAQ:CAPR) 97% Share Price Wipe Out?Did You Manage To Avoid Capricor Therapeutics' (NASDAQ:CAPR) 97% Share Price Wipe Out?
finance.yahoo.com - April 24 at 9:33 AM
Blood Pressure Disorders Drug Market Usage, Dosage and Side Effects Analysis 2020Blood Pressure Disorders Drug Market Usage, Dosage and Side Effects Analysis 2020
www.marketwatch.com - April 15 at 1:32 PM
This Penny Stock Joins the Fight Against Coronavirus; Analyst Sees Triple-Digit UpsideThis Penny Stock Joins the Fight Against Coronavirus; Analyst Sees Triple-Digit Upside
finance.yahoo.com - April 6 at 8:31 PM
Thinking about buying stock in Capricor Therapeutics, Chesapeake Energy Corp, electroCore, General Motors, or MGM Resorts?Thinking about buying stock in Capricor Therapeutics, Chesapeake Energy Corp, electroCore, General Motors, or MGM Resorts?
www.prnewswire.com - April 3 at 4:23 PM
Capricor Initiates Compassionate Use Program for Severe COVID-19 Patients using CAP-1002, its Novel Cell TherapyCapricor Initiates Compassionate Use Program for Severe COVID-19 Patients using CAP-1002, its Novel Cell Therapy
finance.yahoo.com - April 3 at 4:23 PM
Capricor up 55% on potential of exosome platform for coronavirus vaccineCapricor up 55% on potential of exosome platform for coronavirus vaccine
seekingalpha.com - March 24 at 1:34 PM
Capricor Therapeutics (CAPR) CEO Linda Marban on Q4 2019 Results - Earnings Call TranscriptCapricor Therapeutics' (CAPR) CEO Linda Marban on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 19 at 1:08 AM
Capricor Therapeutics EPS in-line, beats on revenueCapricor Therapeutics EPS in-line, beats on revenue
seekingalpha.com - March 18 at 8:08 PM
BRIEF-Capricor Therapeutics Q4 Loss Per Share $0.34BRIEF-Capricor Therapeutics Q4 Loss Per Share $0.34
www.reuters.com - March 18 at 8:08 PM
Capricor Therapeutics, Inc. to Host Earnings CallCapricor Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - March 18 at 8:08 PM
Capricor Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdateCapricor Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - March 18 at 8:08 PM
Capricor Therapeutics Announces Strategic Plan for Exosome Platform Technology Products ExpansionCapricor Therapeutics Announces Strategic Plan for Exosome Platform Technology Products Expansion
finance.yahoo.com - March 17 at 8:36 AM
Capricor Therapeutics to Present Fourth Quarter and Full Year 2019 Financial Results and Recent Corporate Update on March 18Capricor Therapeutics to Present Fourth Quarter and Full Year 2019 Financial Results and Recent Corporate Update on March 18
finance.yahoo.com - March 11 at 6:26 PM
Does Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO Pay Reflect Performance?Does Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO Pay Reflect Performance?
finance.yahoo.com - March 10 at 8:41 AM
Is Capricor Therapeutics (CAPR) Outperforming Other Medical Stocks This Year?Is Capricor Therapeutics (CAPR) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - February 13 at 1:29 PM
Casper Sleep shares slide 13% on second day of trading, falling below $12 IPO issue priceCasper Sleep shares slide 13% on second day of trading, falling below $12 IPO issue price
finance.yahoo.com - February 7 at 1:59 PM
Top Ranked Momentum Stocks to Buy for February 3rdTop Ranked Momentum Stocks to Buy for February 3rd
finance.yahoo.com - February 3 at 1:04 PM
Capricor Therapeutics IncCapricor Therapeutics Inc
www.bloomberg.com - January 31 at 11:54 PM
Dilated Cardiomyopathy Therapeutic Market: Industry Status, Growth and Research Analysis 2020Dilated Cardiomyopathy Therapeutic Market: Industry Status, Growth and Research Analysis 2020
www.marketwatch.com - January 18 at 12:24 AM
Capricor Therapeutics Announces Closing of $5.1 Million Offering Priced At-the-MarketCapricor Therapeutics Announces Closing of $5.1 Million Offering Priced At-the-Market
finance.yahoo.com - December 19 at 3:55 PM
Capricor Therapeutics Announces Pricing of $5.1 Million Offering Priced At-the-MarketCapricor Therapeutics Announces Pricing of $5.1 Million Offering Priced At-the-Market
finance.yahoo.com - December 17 at 3:25 PM
This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.